EP Plenary Session - A Pharmaceutical Strategy for Europe

EP Plenary session - The rise of right-wing extremism and racism in Europe (in light of recent events in Rome)

EP Plenary session - State of play of the implementation of the EU Digital Covid Certificate regulations

EP Plenary session - The situation of sexual and reproductive health and rights in the EU, in the frame of women s health

EP Plenary session - European Social Fund Plus (ESF+) 2021-2027

plenary session - Joint debate EU Digital COVID Certificate

EP Plenary session - Joint debate EU Digital COVID Certificate 44-45

EP Plenary session - Joint debate - Digital green certificate - Union citizens & third countries - The accessibility and affordability of Covid-testing

UN CSW 65 Side event : Gender equality in the Covid-19 recovery

EP Plenary session - Children's Right

EP plenary session- Joint debate - Common Foreign, Security and Defence Policy (Article 36 TEU) and Human Rights

EP plenary session.- EU global strategy on COVID-19 vaccinations

EP Plenary session - Joint debate - Water legislation

EP Plenary session - Council and Commission statements - The new LGBTIQ Equality Strategy

EP Plenary session - Transparency of the Purchase as well as the Access to COVID-19 vaccinations

EP Plenary session - Annual report 2018 on human rights and democracy in the world and European Union's policy on the matter

Hearing of Virginijus SINKEVIČIUS, Commissioner-designate, Environment and Oceans - Q&A

Plenary session- Topical debate (Rule 162) - Fight against cancer

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs debate on Children's Rights.

Children's Rights - Oral question to Commission: MEPs debate

Members of the Public Health (ENVI) and Industry (ITRE) committees debate how to increase capacity and improve delivery of COVID-19 vaccines with pharmaceutical companies (AstraZeneca, Moderna, CureVac, Novavax, Johnson & Johnson, Pfizer Group and Sanofi Pasteur) and Commissioners Thierry Breton and Stella Kyriakides. Statements of MEPs : CANFIN Pascal (Renew, FR), BUŞOI Cristian-Silviu (EPP, RO), GUTELAND Jytte (S&D, SE), BALDASSARRE Simona (ID, IT). Statements of CEOs of pharmaceutical companies : SORIOT Pascal, CEO AstraZeneca, BANCEL Stéphane, CEO Moderna, HAAS Franz-Werner, CEO Curevac, ERCK Stan, CEO Novavax, HWANG Angela, CEO Pfizer, STOFFELS Paul, CEO Johnson & Johnson, TRIOMPHE Thomas, CEO Sanofi.

How to increase the capacity of COVID 19 vaccine production and improve delivery: extracts from the Joint ENVI-ITRE hearing

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Q&A with CEOs of the pharmaceutical industry Pascal SORIOT, Chief Executive Officer, AstraZeneca, Stéphane BANCEL, Chief Executive Officer, Moderna, Franz-Werner HAAS, Chief Executive Officer, CureVac, accompanied by Antony BLANC, Chief Business Officer, Stan ERCK, President & Chief Executive Officer, Novavax.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry

Emer COOKE, Executive Director of the European Medicines Agency, answers questions posed by the members of the Committee on the Environment, Public Health and Food Safety on vaccine authorisation, availability and deployment.

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency EP Committee on the Environment, Public Health and Food Safety: questions/answers with the MEPs

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations. MEPs debate 2/3

EU global strategy on COVID-19 vaccinations: MEPs debate 2/3

On 3rd October, Virginijus SINKEVICIUS, from Lithuania, Commissioner-designate for Environment and Oceans, is heard by the Committee on Fisheries (PECH) and the Committee on the Environment, Public Health and Food Safety (ENVI) of the European Parliament in Brussels to test his general competences, European commitment and specific expertise related to his portfolio. On this occasion, Virginijus SINKEVICIUS has the opportunity in a question and answer session. Questions by the Political group coordinators.

Hearing of Virginijus SINKEVICIUS, Commissioner-designate, Environment and Oceans: Questions and answers (Part 2)

24 výsledků